SUMMT has shown for the first time that a drug can reduce major heart failure clinical outcomes in patients with heart ...

"Obesity contributes to worsening heart failure, and while tirzepatide causes considerable weight loss, research is lacking ...

Pharmacies that make customized medications are asking the federal Food and Drug Administration to protect their right to ...

HF specialists agree these drugs will be key tools in fighting the obesity-related HFpEF epidemic. Hurdles and questions ...

CHICAGO -- A long-acting GIP/GLP-1 receptor agonist conferred significant clinical benefit for people with obesity and ...

The popular weight loss drugs have also been found to reduce other risks, including the risk of death from COVID-19.

Ozempic, Wegovy and other GLP-1 drugs have been shown to curb alcoholism, a new study suggests. Researchers explain why ...

But the agency said later it was re-evaluating the decision that the shortage is over amid litigation, putting compounding of ...

A new study has found that the groundbreaking new class of weight loss drugs may not only be good at treating diabetes, but ...

The study examined GLP-1 drugs, which include semaglutide and tirzepatide. Semaglutide is a key ingredient in Ozempic and Wegovy. Wegovy and Ozempic have also been found to reduce other risks ...

But the agency said later it was re-evaluating the decision that the shortage is over amid litigation, putting compounding of tirzepatide into a gray area. Meanwhile, semaglutide remains on the ...